Research location
Gelnhausen
Hesse, Germany
Advertisement
Research activity in Gelnhausen
Hesse, GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 27 trials and 27 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Gelnhausen
27 linked trials · page 1 of 1A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesNCT04255433 · 2020-05-29 · 1 site observation
COMPLETED
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsNCT02555371 · 2016-01-07 · 1 site observation
COMPLETED
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary SurgeryNCT02466737 · 2015-09-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
Plegridy Observational ProgramNCT02230969 · 2014-11-12 · 1 site observation
COMPLETED
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic SubjectsNCT02135692 · 2014-05-29 · 1 site observation
COMPLETED
Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation
COMPLETED
A Study to Determine Long-term Safety of Mepolizumab in Asthmatic SubjectsNCT01842607 · 2013-05-27 · 1 site observation
COMPLETED
Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 WeeksNCT01772134 · 2013-01-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory AsthmaNCT01691521 · 2012-10-08 · 1 site observation
COMPLETED
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory AsthmaNCT01691508 · 2012-10-01 · 1 site observation
COMPLETED
Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPDNCT01387230 · 2011-07-01 · 1 site observation
COMPLETED
A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDNCT01313637 · 2011-03-01 · 1 site observation
COMPLETED
An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study ANCT01328444 · 2011-03-01 · 1 site observation
COMPLETED
A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01319019 · 2010-12-01 · 1 site observation
COMPLETED
Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).NCT01218126 · 2010-11-04 · 1 site observation
COMPLETED
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsNCT01165138 · 2010-08-20 · 1 site observation
COMPLETED
Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsNCT01134042 · 2010-06-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01054885 · 2009-10-19 · 1 site observation
COMPLETED
Efficacy and Safety Study of GSK679586 in Patients With Severe AsthmaNCT00843193 · 2008-12-09 · 1 site observation
COMPLETED
Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00676052 · 2008-05-16 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.NCT00603382 · 2007-12-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.NCT00603746 · 2007-12-01 · 1 site observation
COMPLETED
Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IVNCT00527826 · 2007-11-01 · 1 site observation
COMPLETED
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic BronchitisNCT00473460 · 2004-10-01 · 1 site observation
COMPLETED
A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.NCT01499446 · 2003-09-01 · 1 site observation
COMPLETED
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseNCT00361959 · 2003-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.